Stockscreener 앱 받기
138.41
6.27%
-9.2458
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
Anil Ranganath Sells 864 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Insider Selling: TransMedics Group (NASDAQ:TMDX) CFO Sells 375 Shares of Stock - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
Nicholas Corcoran Sells 2,966 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) CFO Sells $1,065,211.56 in Stock - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com UK
The medtech firm’s latest quarter showed organ demand – and profits – continuing to rise. - Finimize
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS - MarketBeat
Why TransMedics Group (TMDX) Is Up 9.2% After Strong 2025 Results And 2026 Outlook - simplywall.st
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TD Cowen Health Care Conference - marketscreener.com
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - Yahoo Finance
TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance - timothysykes.com
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
TransMedics Shares Surge Amid Strong Q4 Financial Performance - StocksToTrade
TransMedics’ Shares Surge on Strong Q4 Results and Price Target Raises - StocksToTrade
TransMedics Stock Surges as Analysts Raise Price Targets Amid Strong Earnings - timothysykes.com
TransMedics Stock Surges After Outstanding Q4 Earnings and Strategic Expansion Plans - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9%What's Next? - MarketBeat
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics provides information on impact of release of valuation allowance on deferred tax assets on previously reported quarterly results - marketscreener.com
TransMedics clarifies Q4 tax benefit impact on earnings - Investing.com
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PR Newswire
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group, Inc. (TMDX): A bull case theory - MSN
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? - Yahoo Finance
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2025 Earnings Call Transcript - Insider Monkey
TransMedics Group Stock Plunges 4.3% as $350M Surge Propels It to 390th Most Traded Amid Mystery - Bitget
JP Morgan Maintains Neutral Rating for TMDX with Raised Price Ta - GuruFocus
Needham raises TransMedics stock price target to $174 on beat By Investing.com - Investing.com Canada
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
JPMorgan Chase & Co. Issues Positive Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price - MarketBeat
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Oppenheimer Analyst Says - MarketBeat
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations - Bitget
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
TransMedics Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
TMDX Analyst Rating Update: Piper Sandler Raises Price Target | - GuruFocus
Piper Sandler Forecasts Strong Price Appreciation for TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Evercore ISI Group Raises Price Target for TransMedics Group (TM - GuruFocus
Oppenheimer Adjusts Price Target on TransMedics to $175 From $150, Maintains Outperform Rating - marketscreener.com
Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating - marketscreener.com
TransMedics revenue up 32% to USD 160.8M in Q4 2025 - Medical Buyer
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Needham raises TransMedics stock price target to $174 on beat - Investing.com
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts - Benzinga
TMDX: Needham Raises Price Target to $174, Maintains Buy Rating - GuruFocus
TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook - TechStock²
TransMedics Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:TMDX) 2026-02-25 - Seeking Alpha
TransMedics Group (TMDX) Reports Strong Q4 2025 Growth - GuruFocus
TransMedics Reports Strong Q4 2025 Earnings with Significant Growth - Intellectia AI
TransMedics Group Inc (TMDX): A Strategic SWOT Insight - GuruFocus
TransMedics Group Q4 Earnings Call Highlights - Yahoo Finance
TransMedics Group Inc (TMDX) Q4 2025 Earnings Call Highlights: S - GuruFocus
TransMedics Group Q4 2025 Earnings Call Transcript - MarketBeat
TransMedics (TMDX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
TransMedics (TMDX) Surpasses Q4 Revenue Estimates and Eyes Future Growth - GuruFocus
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
TMDX Projects Strong Revenue Growth for FY26 - GuruFocus
Transmedics Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TransMedics (TMDX) Reports Strong Q4 Earnings, Surpasses Expecta - GuruFocus
TransMedics Group Q4 Net Income, Revenue Rise; Shares Gain After Hours - marketscreener.com
TransMedics surges on earnings beat, solid guidance By Investing.com - Investing.com UK
TransMedics surges on earnings beat, solid guidance - Investing.com
TransMedics: Fourth Quarter Financial Highlights - Bitget
TransMedics: Q4 Earnings Snapshot - marketscreener.com
2.33%
자본화:
|
볼륨(24시간):